drugset / Trial / NCT05414175
A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effectiveness, safety, and tolerability of a 30-week course of mavacamten and the long-term effects of mavacamten in Japanese participants with symptomatic obstructive hypertrophic cardiomyopathy (HCM).
Timeline
- Start
- 2022-08-19
- Primary completion
- 2023-11-27
- Completion
- 2025-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mavacamten | Small molecule | — | — |